Status:
COMPLETED
A Comparison of Patch vs. Pill Estrogen Therapy on Testosterone Levels and Thyroid Tests in Menopausal Women
Lead Sponsor:
Watson Pharmaceuticals
Collaborating Sponsors:
Massachusetts General Hospital
Conditions:
Menopause
Eligibility:
FEMALE
42-70 years
Phase:
PHASE4
Brief Summary
This study compares the effects of 12 weeks of treatment with transdermal versus oral estrogen therapy on testsoterone levels and thyroid tests in healthy, naturally menopausal women.
Eligibility Criteria
Inclusion
- Healthy
- Naturally menopausal women
- Aged 42-70 years
- Currently using combination estrogen-progestin replacement therapy
Exclusion
- Women with contraindications to HRT use, including:Unexplained vaginal bleeding, liver disease, breast or endometrial cancer, venous thromboembolic events
- Thyroid disease
- Adrenal disease
Key Trial Info
Start Date :
January 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT00224094
Start Date
January 1 2002
Last Update
October 15 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114